癌症診斷的全球市場 (2021-2027年):市場預測 (各用途、癌症類型、終端用戶)、COVID-19的影響、地區的展望、用途的潛在性、價格趨勢、市場佔有率

癌症診斷的市場，由於全球的癌症罹患者數增加，至2027年預計大幅度成長。

各用途中，液態切片的部門在預測期間內高年複合成長率發展，預計到2027年表現62億2,330萬美元的規模。中還有各癌症類型，大腸癌的部門在預測期間內預計以約8.6％的年複合成長率發展，到2027年終表現大 規模。

本報告提供全球癌症診斷的市場調查，市場定義和概要，新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析，市場規模的變化、預測，用途、癌症類型、終端用戶、地區/主要國家等各種區分的明細，競爭環境，主要企業簡介等彙整資訊。

目錄

第1章 調查手法

第2章 摘要整理

第3章 癌症診斷產業的考察

• 產業的分類
• 產業形勢
• 對產業的影響要素
  • 成長要素
  • 潛在的風險&課題
• 成長可能性
• COVID-19:影響分析
• 波特分析
• 競爭情形
• PESTEL分析

第4章 癌症診斷市場:各用途

• 主要趨勢
• 癌症生物標記檢驗
  • 市場規模、預測:各地區
• 成像
  • 市場規模、預測:各地區
  • 超音波、放射線
  • 乳房X光攝影
  • MRI掃描
  • PET掃描
  • 電腦斷層掃描
  • SPECT等
• 切片檢查
  • 市場規模、預測:各地區
• 液態生物檢體
  • 市場規模、預測:各地區
• 免疫組織染色
  • 市場規模、預測:各地區
• In situ雜合反應
  • 市場規模、預測:各地區

第5章 癌症診斷市場:各癌症類型

• 主要趨勢
• 膀胱癌
  • 市場規模、預測:各地區
• 乳癌
  • 市場規模、預測:各地區
• 大腸癌
  • 市場規模、預測:各地區
• 子宮內膜癌
  • 市場規模、預測:各地區
• 腎臟癌
  • 市場規模、預測:各地區
• 白血病
  • 市場規模、預測:各地區
• 肝肺癌
  • 市場規模、預測:各地區
• 黑色素瘤
  • 市場規模、預測:各地區
• 非何杰金氏淋巴瘤
  • 市場規模、預測:各地區
• 胰臟癌
  • 市場規模、預測:各地區
• 前列腺癌
  • 市場規模、預測:各地區
• 甲狀腺癌
  • 市場規模、預測:各地區
• 其他
  • 市場規模、預測:各地區

第6章 癌症診斷市場:各終端用戶

• 主要趨勢
• 醫院
  • 市場規模、預測:各地區
• 診斷檢驗實驗室
  • 市場規模、預測:各地區
• 影像診斷中心
  • 市場規模、預測:各地區
• 癌症研究機關
  • 市場規模、預測:各地區

第7章 癌症診斷市場:各地區

• 主要趨勢
• 北美
• 歐洲
• 亞太地區
• 南美
• 中東、非洲

第8章 企業簡介

• 競爭儀表板
• Abbott Laboratories
• AB Sciex Pte. Ltd
• Agilent Technologies Inc
• Becton, Dickinson and Company
• Biocare Medical LLC
• Biocartis
• BioMerieux SA
• Bio-Rad Laboratories
• Cancer Genetics Inc
• GE Healthcare
• Hologic Inc
• Janssen Diagnostics LLC(Johnson & Johnson)
• Leica Biosystem Nussloch GmbH(Danaher Corporation)
• Myriad Genetics, Inc
• Qiagen N.V
• F-Hoffmann-La Roche Ltd
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fischer Scientific

The cancer diagnostics market is anticipated to witness substantial growth through 2027 owing to rising incidences of cancer across the globe.

Recently, industry players have been focusing on product development to gain a competitive edge in the market, which has been favorable for overall business outlook. For instance, in November 2021, Becton, Dickinson and Co., a key medical devices company, launched a fully automated high-throughput diagnostic system for cervical cancer screening, dubbed the BD COR PX/GX System. Approved by the U.S. Food and Drug Administration in August 2021, the system has been designed for use in centralized labs and can handle high-volume processing with increased efficiency.

Furthermore, companies are also implementing lucrative strategies in order to improve their market standing, thereby enhancing global industry dynamics. To cite an instance, in April 2021, Siemens Healthineers AG, a major healthcare company, completed the acquisition of Varian Medical Systems, Inc., a specialist in radiation oncology treatments. With the deal, the companies intended to create a unique and high-integrated portfolio of laboratory diagnostics, imaging, artificial intelligence (AI), and treatment to support the global fight against cancer with significant potential for better value creation.

For extensive analysis, the cancer diagnostics market has been categorized in terms of application, cancer type, end use, and region. Based on application, the market has further been segregated into tumor biomarkers tests, immunohistochemistry, imaging, liquid biopsy, biopsy, and in situ hybridization. The liquid biopsy sub-segment is projected to exceed a valuation of USD 6,223.3 million by 2027, growing at a sizable CAGR through the assessment timeframe.

With respect to cancer type, the market has been bifurcated into breast cancer, leukemia, colon and rectal cancer, bladder cancer, kidney cancer, endometrial cancer, liver-lung cancer, non-Hodgkin lymphoma, melanoma, thyroid cancer, prostate cancer, pancreatic cancer, and others. The colon and rectal cancer sub-segment is expected to progress at around 8.6% CAGR over the analysis period to reach a notable valuation by the end of 2027.

From the end use perspective, the cancer diagnostics market has been divided into diagnostic laboratories, hospitals, cancer research institutes, and diagnostic imaging centers. In 2020, the diagnostic imaging centers sub-segment was valued at more than USD 19,558.9 million and is estimated to grow at a steady pace over 2021-2027.

In the regional landscape, the Latin America cancer diagnostics industry accounted for approximately 7% of the overall market revenue in 2020 and is calculated to register stable revenue growth through the review timeline. Meanwhile, the Middle East & Africa cancer diagnostics market is speculated to grow at a CAGR of above 7.1% over the forecast period.

Table of Contents

Chapter 1 Methodology

• 1.1 Market definitions
• 1.2 Base estimates & working
  • 1.2.1 North America
  • 1.2.2 Europe
  • 1.2.3 Asia Pacific
  • 1.2.4 Latin America
  • 1.2.5 Middle East & Africa
• 1.3 Forecast parameters
• 1.4 Data validation
• 1.5 Data Sources
  • 1.5.1 Secondary
    • 1.5.1.1 Paid sources
    • 1.5.1.2 Unpaid sources
  • 1.5.2 Primary

Chapter 2 Executive Summary

• 2.1 Cancer diagnostics industry 360 degree synopsis, 2016-2027
  • 2.1.1 Business trends
  • 2.1.2 Application trends
  • 2.1.3 Cancer type trends
  • 2.1.4 End-use trends
  • 2.1.5 Regional trends

Chapter 3 Cancer Diagnostics Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2016 - 2027
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Rising incidence of cancer globally
    • 3.3.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
    • 3.3.1.3 Growing number of diagnostic laboratories in developed countries
    • 3.3.1.4 Technological advancements in developed countries
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 High capital investment coupled with high cost associated with diagnostic imaging system
    • 3.3.2.2 Risk related with high radiation exposure affecting use of CT scanner
• 3.4 Growth potential analysis
  • 3.4.1 By application
  • 3.4.2 By cancer type
  • 3.4.3 By end-use
• 3.5 COVID-19 impact analysis
• 3.6 Porter's analysis
• 3.7 Competitive landscape
  • 3.7.1 Company matrix analysis, 2020
• 3.8 PESTEL analysis

Chapter 4 Cancer Diagnostics Market, By Application

• 4.1 Key segment trends
• 4.2 Tumor biomarkers tests
  • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
• 4.3 Imaging
  • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.2 Ultrasound and radiology
    • 4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.3 Mammography
    • 4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.4 MRI scan
    • 4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.5 PET scan
    • 4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.6 CT scan
    • 4.3.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3.7 SPECT & others
    • 4.3.7.1 Market size, by region, 2016 - 2027 (USD Million)
• 4.4 Biopsy
  • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
• 4.5 Liquid biopsy
  • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)
• 4.6 Immunohistochemistry
  • 4.6.1 Market size, by region, 2016 - 2027 (USD Million)
• 4.7 In situ hybridization
  • 4.7.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Cancer Diagnostics Market, By Cancer type

• 5.1 Key segment trends
• 5.2 Bladder cancer
  • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.3 Breast cancer
  • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.4 Colon and rectal cancer
  • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.5 Endometrial cancer
  • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.6 Kidney cancer
  • 5.6.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.7 Leukemia
  • 5.7.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.8 Liver-lung cancer
  • 5.8.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.9 Melanoma
  • 5.9.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.10 Non-Hodgkin lymphoma
  • 5.10.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.11 Pancreatic cancer
  • 5.11.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.12 Prostate cancer
  • 5.12.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.13 Thyroid cancer
  • 5.13.1 Market size, by region, 2016 - 2027 (USD Million)
• 5.14 Others
  • 5.14.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Cancer Diagnostics Market, By End-use

• 6.1 Key segment trends
• 6.2 Hospitals
  • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
• 6.3 Diagnostic laboratories
  • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
• 6.4 Diagnostic imaging centers
  • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
• 6.5 Cancer research institutes
  • 6.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Cancer Diagnostics Market, By Region

• 7.1 Key regional trends
• 7.2 North America
  • 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
  • 7.2.2 Market size, by application, 2016 - 2027 (USD Million)
    • 7.2.2.1 Market size, by imaging, 2016 - 2027 (USD Million)
  • 7.2.3 Market size, by cancer type, 2016 - 2027 (USD Million)
  • 7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.2.5 U.S.
    • 7.2.5.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.2.5.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.2.5.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.2.6 Canada
    • 7.2.6.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.2.6.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.2.6.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
• 7.3 Europe
  • 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
  • 7.3.2 Market size, by application, 2016 - 2027 (USD Million)
    • 7.3.2.1 Market size, by imaging, 2016 - 2027 (USD Million)
  • 7.3.3 Market size, by cancer type, 2016 - 2027 (USD Million)
  • 7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.5 Germany
    • 7.3.5.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.5.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.5.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.6 UK
    • 7.3.6.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.6.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.6.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.7 France
    • 7.3.7.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.7.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.7.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.8 Italy
    • 7.3.8.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.8.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.8.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.9 Spain
    • 7.3.9.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.9.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.9.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3.10 Russia
    • 7.3.10.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.10.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.3.10.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.3.10.3 Market size, by end-use, 2016 - 2027 (USD Million)
• 7.4 Asia Pacific
  • 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
  • 7.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 7.4.2.1 Market size, by imaging, 2016 - 2027 (USD Million)
  • 7.4.3 Market size, by cancer type, 2016 - 2027 (USD Million)
  • 7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4.5 Japan
    • 7.4.5.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.4.5.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.4.5.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4.6 China
    • 7.4.6.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.4.6.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.4.6.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4.7 India
    • 7.4.7.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.4.7.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.4.7.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4.8 Australia
    • 7.4.8.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.4.8.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.4.8.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.4.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
• 7.5 Latin America
  • 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
  • 7.5.2 Market size, by application, 2016 - 2027 (USD Million)
    • 7.5.2.1 Market size, by imaging, 2016 - 2027 (USD Million)
  • 7.5.3 Market size, by cancer type, 2016 - 2027 (USD Million)
  • 7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.5.5 Brazil
    • 7.5.5.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.5.5.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.5.5.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.5.6 Mexico
    • 7.5.6.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.5.6.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.5.6.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.5.7 Argentina
    • 7.5.7.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.5.7.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.5.7.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.5.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
• 7.6 MEA
  • 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
  • 7.6.2 Market size, by application, 2016 - 2027 (USD Million)
    • 7.6.2.1 Market size, by imaging, 2016 - 2027 (USD Million)
  • 7.6.3 Market size, by cancer type, 2016 - 2027 (USD Million)
  • 7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.6.5 South Africa
    • 7.6.5.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.6.5.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.6.5.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.6.6 Saudi Arabia
    • 7.6.6.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.6.6.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.6.6.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.6.7 UAE
    • 7.6.7.1 Market size, by application, 2016 - 2027 (USD Million)
      • 7.6.7.1.1 Market size, by imaging, 2016 - 2027 (USD Million)
    • 7.6.7.2 Market size, by cancer type, 2016 - 2027 (USD Million)
    • 7.6.7.3 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

• 8.1 Competitive dashboard, 2020
• 8.2 Abbott Laboratories
  • 8.2.1 Business overview
  • 8.2.2 Financial data
  • 8.2.3 Product landscape
  • 8.2.4 Strategic outlook
  • 8.2.5 SWOT analysis
• 8.3 AB Sciex Pte. Ltd
  • 8.3.1 Business overview
  • 8.3.2 Financial data
  • 8.3.3 Product landscape
  • 8.3.4 Strategic outlook
  • 8.3.5 SWOT analysis
• 8.4 Agilent Technologies Inc
  • 8.4.1 Business overview
  • 8.4.2 Financial data
  • 8.4.3 Product landscape
  • 8.4.4 Strategic outlook
  • 8.4.5 SWOT analysis
• 8.5 Becton, Dickinson and Company
  • 8.5.1 Business overview
  • 8.5.2 Financial data
  • 8.5.3 Product landscape
  • 8.5.4 Strategic outlook
  • 8.5.5 SWOT analysis
• 8.6 Biocare Medical LLC
  • 8.6.1 Business overview
  • 8.6.2 Financial data
  • 8.6.3 Product landscape
  • 8.6.4 Strategic outlook
  • 8.6.5 SWOT analysis
• 8.7 Biocartis
  • 8.7.1 Business overview
  • 8.7.2 Financial data
  • 8.7.3 Product landscape
  • 8.7.4 Strategic outlook
  • 8.7.5 SWOT analysis
• 8.8 BioMerieux SA
  • 8.8.1 Business overview
  • 8.8.2 Financial data
  • 8.8.3 Product landscape
  • 8.8.4 Strategic outlook
  • 8.8.5 SWOT analysis
• 8.9 Bio-Rad Laboratories
  • 8.9.1 Business overview
  • 8.9.2 Financial data
  • 8.9.3 Product landscape
  • 8.9.4 Strategic outlook
  • 8.9.5 SWOT analysis
• 8.10 Cancer Genetics Inc
  • 8.10.1 Business overview
  • 8.10.2 Financial data
  • 8.10.3 Product landscape
  • 8.10.4 Strategic outlook
  • 8.10.5 SWOT analysis
• 8.11 GE Healthcare
  • 8.11.1 Business overview
  • 8.11.2 Financial data
  • 8.11.3 Product landscape
  • 8.11.4 Strategic outlook
  • 8.11.5 SWOT analysis
• 8.12 Hologic Inc
  • 8.12.1 Business overview
  • 8.12.2 Financial data
  • 8.12.3 Product landscape
  • 8.12.4 Strategic outlook
  • 8.12.5 SWOT analysis
• 8.13 Janssen Diagnostics LLC (Johnson & Johnson)
  • 8.13.1 Business overview
  • 8.13.2 Financial data
  • 8.13.3 Product landscape
  • 8.13.4 Strategic outlook
  • 8.13.5 SWOT analysis
• 8.14 Leica Biosystem Nussloch GmbH (Danaher Corporation)
  • 8.14.1 Business overview
  • 8.14.2 Financial data
  • 8.14.3 Product landscape
  • 8.14.4 Strategic outlook
  • 8.14.5 SWOT analysis
• 8.15 Myriad Genetics, Inc
  • 8.15.1 Business overview
  • 8.15.2 Financial data
  • 8.15.3 Product landscape
  • 8.15.4 Strategic outlook
  • 8.15.5 SWOT analysis
• 8.16 Qiagen N.V
  • 8.16.1 Business overview
  • 8.16.2 Financial data
  • 8.16.3 Product landscape
  • 8.16.4 Strategic outlook
  • 8.16.5 SWOT analysis
• 8.17 F-Hoffmann-La Roche Ltd
  • 8.17.1 Business overview
  • 8.17.2 Financial data
  • 8.17.3 Product landscape
  • 8.17.4 Strategic outlook
  • 8.17.5 SWOT analysis
• 8.18 Siemens Healthineers
  • 8.18.1 Business overview
  • 8.18.2 Financial data
  • 8.18.3 Product landscape
  • 8.18.4 Strategic outlook
  • 8.18.5 SWOT analysis
• 8.19 Sysmex Corporation
  • 8.19.1 Business overview
  • 8.19.2 Financial data
  • 8.19.3 Product landscape
  • 8.19.4 Strategic outlook
  • 8.19.5 SWOT analysis
• 8.20 Thermo Fischer Scientific
  • 8.20.1 Business overview
  • 8.20.2 Financial data
  • 8.20.3 Product landscape
  • 8.20.4 Strategic outlook
  • 8.20.5 SWOT analysis

Data Tables

• TABLE 1 Cancer diagnostics industry 360 degree synopsis, 2016 - 2027
• TABLE 2 Global cancer diagnostics market, 2016 - 2020 (USD Million)
• TABLE 3 Global cancer diagnostics market, 2021 - 2027 (USD Million)
• TABLE 4 Global cancer diagnostics market, by application, 2016 - 2020 (USD Million)
• TABLE 5 Global cancer diagnostics market, by application, 2021 - 2027 (USD Million)
• TABLE 6 Global cancer diagnostics market, by cancer type, 2016 - 2020 (USD Million)
• TABLE 7 Global cancer diagnostics market, by cancer type, 2021 - 2027 (USD Million)
• TABLE 8 Global cancer diagnostics market, by end-use, 2016 - 2020 (USD Million)
• TABLE 9 Global cancer diagnostics market, by end-use, 2021 - 2027 (USD Million)
• TABLE 10 Global cancer diagnostics market, by region, 2016 - 2020 (USD Million)
• TABLE 11 Global cancer diagnostics market, by region, 2021 - 2027 (USD Million)
• TABLE 12 Industry impact forces
• TABLE 13 Tumor biomarkers tests market size, by region, 2016 - 2020 (USD Million)
• TABLE 14 Tumor biomarkers tests market size, by region, 2021 - 2027 (USD Million)
• TABLE 15 Imaging market size, by region, 2016 - 2020 (USD Million)
• TABLE 16 Imaging market size, by region, 2021 - 2027 (USD Million)
• TABLE 17 Ultrasound and radiology market size, by region, 2016 - 2020 (USD Million)
• TABLE 18 Ultrasound and radiology market size, by region, 2021 - 2027 (USD Million)
• TABLE 19 Mammography market size, by region, 2016 - 2020 (USD Million)
• TABLE 20 Mammography market size, by region, 2021 - 2027 (USD Million)
• TABLE 21 MRI Scan market size, by region, 2016 - 2020 (USD Million)
• TABLE 22 MRI Scan market size, by region, 2021 - 2027 (USD Million)
• TABLE 23 PET Scan market size, by region, 2016 - 2020 (USD Million)
• TABLE 24 PET Scan market size, by region, 2021 - 2027 (USD Million)
• TABLE 25 CT Scan market size, by region, 2016 - 2020 (USD Million)
• TABLE 26 CT Scan market size, by region, 2021 - 2027 (USD Million)
• TABLE 27 SPECT and others market size, by region, 2016 - 2020 (USD Million)
• TABLE 28 SPECT and others market size, by region, 2021 - 2027 (USD Million)
• TABLE 29 Biopsy market size, by region, 2016 - 2020 (USD Million)
• TABLE 30 Biopsy market size, by region, 2021 - 2027 (USD Million)
• TABLE 31 Liquid biopsy market size, by region, 2016 - 2020 (USD Million)
• TABLE 32 Liquid biopsy market size, by region, 2021 - 2027 (USD Million)
• TABLE 33 Immunohistochemistry market size, by region, 2016 - 2020 (USD Million)
• TABLE 34 Immunohistochemistry market size, by region, 2021 - 2027 (USD Million)
• TABLE 35 In situ hybridization market size, by region, 2016 - 2020 (USD Million)
• TABLE 36 In situ hybridization market size, by region, 2021 - 2027 (USD Million)
• TABLE 37 Bladder cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 38 Bladder cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 39 Breast cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 40 Breast cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 41 Colon and rectal cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 42 Colon and rectal cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 43 Endometrial cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 44 Endometrial cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 45 Kidney cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 46 Kidney cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 47 Leukemia market size, by region, 2016 - 2020 (USD Million)
• TABLE 48 Leukemia market size, by region, 2021 - 2027 (USD Million)
• TABLE 49 Liver-lung cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 50 Liver-lung cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 51 Melanoma market size, by region, 2016 - 2020 (USD Million)
• TABLE 52 Melanoma market size, by region, 2021 - 2027 (USD Million)
• TABLE 53 Non-Hodgkin lymphoma market size, by region, 2016 - 2020 (USD Million)
• TABLE 54 Non-Hodgkin lymphoma market size, by region, 2021 - 2027 (USD Million)
• TABLE 55 Pancreatic cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 56 Pancreatic cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 57 Prostate cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 58 Prostate cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 59 Thyroid cancer market size, by region, 2016 - 2020 (USD Million)
• TABLE 60 Thyroid cancer market size, by region, 2021 - 2027 (USD Million)
• TABLE 61 Others market size, by region, 2016 - 2020 (USD Million)
• TABLE 62 Others market size, by region, 2021 - 2027 (USD Million)
• TABLE 63 Hospitals market size, by region, 2016 - 2020 (USD Million)
• TABLE 64 Hospitals market size, by region, 2021 - 2027 (USD Million)
• TABLE 65 Diagnostic laboratories market size, by region, 2016 - 2020 (USD Million)
• TABLE 66 Diagnostic laboratories market size, by region, 2021 - 2027 (USD Million)
• TABLE 67 Diagnostic imaging centers market size, by region, 2016 - 2020 (USD Million)
• TABLE 68 Diagnostic imaging centers market size, by region, 2021 - 2027 (USD Million)
• TABLE 69 Cancer research institutes market size, by region, 2016 - 2020 (USD Million)
• TABLE 70 Cancer research institutes market size, by region, 2021 - 2027 (USD Million)
• TABLE 71 North America cancer diagnostics market size, by country, 2016 - 2020 (USD Million)
• TABLE 72 North America cancer diagnostics market size, by country, 2021 - 2027 (USD Million)
• TABLE 73 North America cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 74 North America cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 75 North America cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 76 North America cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 77 North America cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 78 North America cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 79 North America cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 80 North America cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 81 U.S. cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 82 U.S. cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 83 U.S. cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 84 U.S. cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 85 U.S. cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 86 U.S. cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 87 U.S. cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 88 U.S. cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 89 Canada cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 90 Canada cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 91 Canada cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 92 Canada cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 93 Canada cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 94 Canada cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 95 Canada cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 96 Canada cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 97 Europe cancer diagnostics market size, by country, 2016 - 2020 (USD Million)
• TABLE 98 Europe cancer diagnostics market size, by country, 2021 - 2027 (USD Million)
• TABLE 99 Europe cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 100 Europe cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 101 Europe cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 102 Europe cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 103 Europe cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 104 Europe cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 105 Europe cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 106 Europe cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 107 Germany cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 108 Germany cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 109 Germany cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 110 Germany cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 111 Germany cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 112 Germany cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 113 Germany cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 114 Germany cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 115 UK cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 116 UK cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 117 UK cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 118 UK cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 119 UK cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 120 UK cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 121 UK cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 122 UK cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 123 France cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 124 France cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 125 France cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 126 France cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 127 France cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 128 France cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 129 France cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 130 France cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 131 Italy cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 132 Italy cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 133 Italy cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 134 Italy cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 135 Italy cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 136 Italy cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 137 Italy cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 138 Italy cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 139 Spain cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 140 Spain cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 141 Spain cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 142 Spain cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 143 Spain cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 144 Spain cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 145 Spain cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 146 Spain cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 147 Russia cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 148 Russia cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 149 Russia cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 150 Russia cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 151 Russia cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 152 Russia cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 153 Russia cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 154 Russia cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 155 Asia Pacific cancer diagnostics market size, by country, 2016 - 2020 (USD Million)
• TABLE 156 Asia Pacific cancer diagnostics market size, by country, 2021 - 2027 (USD Million)
• TABLE 157 Asia Pacific cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 158 Asia Pacific cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 159 Asia Pacific cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 160 Asia Pacific cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 161 Asia Pacific cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 162 Asia Pacific cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 163 Asia Pacific cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 164 Asia Pacific cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 165 China cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 166 China cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 167 China cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 168 China cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 169 China cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 170 China Cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 171 China cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 172 China cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 173 India cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 174 India cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 175 India cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 176 India cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 177 India cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 178 India cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 179 India cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 180 India cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 181 Japan cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 182 Japan cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 183 Japan cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 184 Japan cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 185 Japan cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 186 Japan cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 187 Japan cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 188 Japan cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 189 Australia cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 190 Australia cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 191 Australia cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 192 Australia cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 193 Australia cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 194 Australia cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 195 Australia cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 196 Australia cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 197 Latin America cancer diagnostics market size, by country, 2016 - 2020 (USD Million)
• TABLE 198 Latin America cancer diagnostics market size, by country, 2021 - 2027 (USD Million)
• TABLE 199 Latin America cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 200 Latin America cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 201 Latin America cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 202 Latin America cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 203 Latin America cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 204 Latin America cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 205 Latin America cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 206 Latin America cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 207 Brazil cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 208 Brazil cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 209 Brazil cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 210 Brazil cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 211 Brazil cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 212 Brazil cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 213 Brazil cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 214 Brazil cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 215 Argentina cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 216 Argentina cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 217 Argentina cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 218 Argentina cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 219 Argentina cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 220 Argentina cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 221 Argentina cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 222 Argentina cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 223 Mexico cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 224 Mexico cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 225 Mexico cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 226 Mexico cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 227 Mexico cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 228 Mexico cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 229 Mexico market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 230 Mexico cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 231 MEA cancer diagnostics market size, by country, 2016 - 2020 (USD Million)
• TABLE 232 MEA cancer diagnostics market size, by country, 2021 - 2027 (USD Million)
• TABLE 233 MEA cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 234 MEA cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 235 MEA cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 236 MEA cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 237 MEA cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 238 MEA cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 239 MEA cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 240 MEA cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 241 South Africa cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 242 South Africa cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 243 South Africa cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 244 South Africa cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 245 South Africa cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 246 South Africa cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 247 South Africa cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 248 South Africa cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 249 Saudi Arabia cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 250 Saudi Arabia cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 251 Saudi Arabia cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 252 Saudi Arabia cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 253 Saudi Arabia cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 254 Saudi Arabia cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 255 Saudi Arabia cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 256 Saudi Arabia cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)
• TABLE 257 UAE cancer diagnostics market size, by application, 2016 - 2020 (USD Million)
• TABLE 258 UAE cancer diagnostics market size, by application, 2021 - 2027 (USD Million)
• TABLE 259 UAE cancer diagnostics market size, by imaging, 2016 - 2020 (USD Million)
• TABLE 260 UAE cancer diagnostics market size, by imaging, 2021 - 2027 (USD Million)
• TABLE 261 UAE cancer diagnostics market size, by cancer type, 2016 - 2020 (USD Million)
• TABLE 262 UAE cancer diagnostics market size, by cancer type, 2021 - 2027 (USD Million)
• TABLE 263 UAE cancer diagnostics market size, by end-use, 2016 - 2020 (USD Million)
• TABLE 264 UAE cancer diagnostics market size, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

• FIG. 1 Top-down approach
• FIG. 2 Breakdown of primary participants
• FIG. 3 Cancer diagnostics industry 360 degree synopsis
• FIG. 4 Industry segmentation
• FIG. 5 Global cancer diagnostics market, 2016 - 2027 (USD Mn)
• FIG. 6 Growth potential analysis, by application
• FIG. 7 Growth potential analysis, by cancer type
• FIG. 8 Growth potential analysis, by end-use
• FIG. 9 Porter's analysis
• FIG. 10 Company matrix analysis, 2020
• FIG. 11 PESTEL analysis
• FIG. 12 Key segment trends, by application
• FIG. 13 Key segment trends, by cancer type
• FIG. 14 Key segment trends, by end-use
• FIG. 15 Key regional trends
• FIG. 16 Competitive dashboard